NCT06795451View on ClinicalTrials.gov

Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic Domains

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

February 25, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Depression - Major Depressive Disorder
Interventions
DEVICE

transcutaneous spinal direct current stimulation

transcutaneous spinal direct current stimulation

Trial Locations (1)

45040

RECRUITING

Lindner Center of Hope, Mason

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Cincinnati

OTHER